Midazolam for PONV. What's new?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to T Di Florio.
Explore the source record for details and available documents.
The effect of intravenous midazolam on persistent postoperative nausea and vomiting (PONV) was compared to placebo in a prospective randomized double-blind study. Twenty patients aged 18 to 82 years with persistent PONV resistant to standard anti-emetics and present for greater than six hours were randomized to receive either an intravenous infusion of midazolam 1.0 mg/h or placebo. Nausea (P = 0.04), vomiting (P = 0.02) and the use of rescue anti-emetics (P = 0.003) were significantly less in the midazolam group. We conclude that low-dose intravenous infusion of midazolam significantly reduces persistent PONV.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.